Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Progesterone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Utrogestan 100mg capsules
0604012S0BDAAAL
|
Utrogestan | Progesterone | Endocrine System | 129,001 |
|
Progesterone micronised 100mg capsules
0604012S0AAALAL
|
Progesterone | Progesterone | Endocrine System | 127,984 |
|
Gepretix 100mg capsules
0604012S0BQAAAL
|
Gepretix | Progesterone | Endocrine System | 19,407 |
|
Progesterone 400mg pessaries
0604012S0AAAFAF
|
Progesterone | Progesterone | Endocrine System | 3,808 |
|
Cyclogest 400mg pessaries
0604012S0BBABAF
|
Cyclogest | Progesterone | Endocrine System | 3,216 |
|
Utrogestan 200mg vaginal capsules with applicators
0604012S0BDADBZ
|
Utrogestan | Progesterone | Endocrine System | 2,163 |
|
Progesterone micronised 200mg vaginal capsules
0604012S0AABZBZ
|
Progesterone | Progesterone | Endocrine System | 1,287 |
|
Cyclogest 200mg pessaries
0604012S0BBAAAE
|
Cyclogest | Progesterone | Endocrine System | 1,274 |
|
Progesterone 200mg pessaries
0604012S0AAAEAE
|
Progesterone | Progesterone | Endocrine System | 1,218 |
|
Lubion 25mg/1.112ml solution for injection vials
0604012S0BPABCC
|
Lubion | Progesterone | Endocrine System | 91 |
|
Crinone 8% progesterone vaginal gel
0604012S0BGABAW
|
Crinone | Progesterone | Endocrine System | 75 |
|
Progesterone 100mg pessaries
0604012S0AAANAN
|
Progesterone | Progesterone | Endocrine System | 71 |
|
Progesterone 8% vaginal gel 1.125g applicators
0604012S0AAAWAW
|
Progesterone | Progesterone | Endocrine System | 70 |
|
Progesterone 25mg/1.112ml solution for injection vials
0604012S0AACCCC
|
Progesterone | Progesterone | Endocrine System | 29 |
|
Lutigest 100mg vaginal tablets
0604012S0BNAAAN
|
Lutigest | Progesterone | Endocrine System | 28 |
|
Progesterone micronised 300mg vaginal capsules
0604012S0AACDCD
|
Progesterone | Progesterone | Endocrine System | 3 |
|
Utrogestan 300mg vaginal capsules
0604012S0BDAECD
|
Utrogestan | Progesterone | Endocrine System | 3 |
|
Progesterone 100mg/1ml solution for injection ampoules
0604012S0AACACA
|
Progesterone | Progesterone | Endocrine System | 1 |
|
Progesterone micronised 200mg capsules
0604012S0AABWBW
|
Progesterone | Progesterone | Endocrine System | 1 |
|
Utrogestan 200mg capsules
0604012S0BDACBW
|
Utrogestan | Progesterone | Endocrine System | 1 |
|
Crinone 4% progesterone vaginal gel
0604012S0BGAAAV
|
Crinone | Progesterone | Endocrine System | No data available |
|
Gepretix 200mg capsules
0604012S0BQABBW
|
Gepretix | Progesterone | Endocrine System | No data available |
|
Gestone 100mg/2ml solution for injection ampoules
0604012S0BCADAH
|
Gestone | Progesterone | Endocrine System | No data available |
|
Gestone 25mg/1ml solution for injection ampoules
0604012S0BCABAC
|
Gestone | Progesterone | Endocrine System | No data available |
|
Gestone 50mg/1ml solution for injection ampoules
0604012S0BCACAD
|
Gestone | Progesterone | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.